Cite
Llerena S, García-Díaz N, Curiel-Olmo S, et al. Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget. 2018;9(56):30869-30882doi: 10.18632/oncotarget.25766.
Llerena, S., García-Díaz, N., Curiel-Olmo, S., Agraz-Doblas, A., García-Blanco, A., Pisonero, H., Varela, M., Santibáñez, M., Almaraz, C., Cereceda, L., Martínez, N., Arias-Loste, M. T., Puente, �. �., Martín-Ramos, L., de Lope, C. R., Castillo-Suescun, F., Cagigas-Fernandez, C., Isidro, P., Lopez-López, C., Lopez-Hoyos, M., Llorca, J., Agüero, J., Crespo-Facorro, B., Varela, I., Piris, M. �. �., Crespo, J., & Vaqué, J. P. (2018). Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget, 9(56), 30869-30882. https://doi.org/10.18632/oncotarget.25766
Llerena, Susana, et al. "Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR." Oncotarget vol. 9,56 (2018): 30869-30882. doi: https://doi.org/10.18632/oncotarget.25766
Llerena S, García-Díaz N, Curiel-Olmo S, Agraz-Doblas A, García-Blanco A, Pisonero H, Varela M, Santibáñez M, Almaraz C, Cereceda L, Martínez N, Arias-Loste MT, Puente Á, Martín-Ramos L, de Lope CR, Castillo-Suescun F, Cagigas-Fernandez C, Isidro P, Lopez-López C, Lopez-Hoyos M, Llorca J, Agüero J, Crespo-Facorro B, Varela I, Piris MÁ, Crespo J, Vaqué JP. Applied diagnostics in liver cancer. Efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR. Oncotarget. 2018 Jul 20;9(56):30869-30882. doi: 10.18632/oncotarget.25766. eCollection 2018 Jul 20. PMID: 30112114; PMCID: PMC6089396.
Copy
Download .nbib